1 completed, 1 terminated, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Hypopharynx Cancer: new trials by email Literature Review of Hypopharynx Cancer trials Research Report on Hypopharynx Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers Zimberelimab, Etrumadenant, Cisplatin - Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck | Phase 1 | Withdrawn | Jennifer Choe | 2023-12-31 | 2023-11-30 | |
| Pembrolizumab in Combination With CRT for LA-SCCHN pembrolizumab (MK-3475), Cisplatin, Radiation - Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1 | Completed | Sanford Health | 59 | 2015-11-01 | 2025-10-07 |
| Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Motexafin Gadolinium Injection - Head and Neck Cancer, Oropharynx Cancer | Phase 1 | Terminated | Pharmacyclics LLC. | 18 | 2007-05-08 |
Head and Neck Neoplasms (3) · Hypopharyngeal Neoplasms (3) · Laryngeal Neoplasms (3) · Oropharyngeal Neoplasms (3) · Mouth Neoplasms (2) · Carcinoma, Squamous Cell (1) · Laryngeal Diseases (1) · Pharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tonsillar Neoplasms (1)
Neoplasms (3) · Neoplasms by Site (3) · Otorhinolaryngologic Diseases (3) · Otorhinolaryngologic Neoplasms (3) · Pharyngeal Diseases (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Stomatognathic Diseases (3) · Carcinoma (2) · Laryngeal Diseases (2) · Mouth Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Pharyngeal Neoplasms (2) · Carcinoma, Squamous Cell (1)
Cisplatin (2) · Radiation (2) · motexafin gadolinium (1) · pembrolizumab (1) · zimberelimab (1)
Jennifer Choe (1) · Pharmacyclics LLC. (1) · Sanford Health (1)
United States (2)
Jennifer Choe, MD, PhD (1) · Steven F Powell, MD (1)